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Abstract
Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used to
perform mediastinal lymph node sampling. However, little information is available on polymerase chain reaction
for Mycobacterium tuberculosis (TB-PCR) using EBUS-TBNA samples in patients with intrathoracic granulomatous
lymphadenopathy (IGL).
Methods: A retrospective study using a prospectively collected database was performed from January 2010 to
December 2014 to evaluate the efficacy of the TB-PCR test using EBUS-TBNA samples in patients with IGL. During
the study period, 87 consecutive patients with isolated intrathoracic lymphadenopathy who received EBUS-TBNA
were registered and 46 patients with IGL were included.
Results: Of the 46 patients with IGL, tuberculous lymphadenitis and sarcoidosis were diagnosed in 16 and 30
patients, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of TB-PCR
for tuberculous lymphadenitis were 56, 100, 100, and 81 %, respectively. The overall diagnostic accuracy of TB-PCR for
tuberculous lymphadenitis was 85 %. In addition, seven (17 %) patients had non-diagnostic results from a histological
examination and all of them had non-diagnostic microbiological results of an acid-fast bacilli smear and culture. Four
(57 %) of the seven patients with non-diagnostic results had positive TB-PCR results, and anti-tuberculosis treatment led
to clinical and radiological improvement in all of the patients.
Conclusions: TB-PCR using EBUS-TBNA samples is a useful laboratory test for diagnosing IGL. Moreover, this technique
can prevent further invasive evaluation in patients whose histological and microbiological tests are non-diagnostic.
Keywords: Endobronchial ultrasound-guided transbronchial needle aspiration, Polymerase chain reaction, Sarcoidosis,
Sensitivity and specificity, Tuberculous lymphadenitis
Background
Intrathoracic granulomatous lymphadenopathies (IGLs),
such as tuberculous lymphadenitis and sarcoidosis, are
frequently encountered by respiratory physicians, and
their diagnosis is based on histological and microbio-
logical tests [1–3]. Conventional transbronchial needle
aspiration or mediastinoscopy has traditionally been
used to perform lymph node biopsy for histological
examinations, as well as for stains and cultures for acid-
fast organisms [4–6]. With the recent advent of endo-
bronchial ultrasound, endobronchial ultrasound-guided
transbronchial needle aspiration (EBUS-TBNA) has been
widely used to perform mediastinal lymph node biopsy
or aspiration. There is increasing evidence regarding
EBUS-TBNA as the first examination of choice in the
evaluation of patients with IGL [7–9].
Most IGLs comprise tuberculous lymphadenitis and
sarcoidosis. Occasionally, differentiating between these
IGLs using a histological examination alone is difficult.
Moreover, the diagnostic yield of acid-fast bacilli culture
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is still unsatisfactory, although such culture is considered
the gold standard diagnostic method for tuberculosis. In
addition to histological and microbiological tests, poly-
merase chain reaction for Mycobacterium tuberculosis
(TB-PCR) is recognized as a useful test in the differential
diagnosis of tuberculous lymphadenitis and sarcoidosis
[10]. However, little information is available on TB-PCR
using EBUS-TBNA samples. Therefore, we conducted
this study to examine the diagnostic performance of TB-
PCR using EBUS-TBNA samples in patients with IGL.
We analyzed a prospectively collected database in South
Korea, where the incidence of tuberculosis is intermediate
(97/100,000 per year) [11].
Methods
Study population
From January 2010 to December 2014, a retrospective
study with a prospectively collected database was
performed to evaluate the efficacy of TB-PCR using
EBUS-TBNA samples in patients with IGL at Pusan
National University Hospital (university-affiliated, tertiary
referral hospital in Busan, South Korea). During the study
period, all consecutive patients who received EBUS-TBNA
were prospectively registered. As a result, 87 patients
with isolated intrathoracic lymphadenopathy, defined
as lymphadenopathy without lung parenchymal abnormal-
ities, received EBUS-TBNA. Fifty patients were diagnosed
with IGL (Fig. 1). Of the 50 selected patients with IGL,
four who were not subjected to TB-PCR were excluded
from the analysis. Therefore, 46 patients with IGL
were finally included in the present study.
The Institutional Review Board of Pusan National
University Hospital approved this study (No. E-2015040).
Informed consent was waived because of the retrospective
nature of the study.
EBUS-TBNA procedure
All bronchoscopic procedures were performed under
conscious sedation with local anesthesia by three pul-
monary physicians (Eom JS, Mok JH, and Lee K). Before
EBUS-TBNA, conventional bronchoscopy was conducted
in a standard fashion for airway inspection and adminis-
tration of lidocaine into the tracheobronchial tree via the
working channel of the bronchoscope. Following conven-
tional bronchoscopy, EBUS-TBNA was performed using a
dedicated bronchoscope with a linear ultrasound trans-
ducer (BF-UC260F-OL8; Olympus, Tokyo, Japan). Sys-
temic assessment of the mediastinal, hilar, and interlobar
lymph nodes was made based on computed tomography
(CT) findings [12], and target lymph nodes were
punctured with a 22-gauge needle (NA-201SX-4022;
Olympus, Tokyo, Japan) under real-time ultrasound
guidance. Two or more punctures were performed
on each target lymph node until at least two tissue
core specimens were obtained. One of the tissue core
specimens was placed in formalin for histological examin-
ation. Other tissue core specimens that were placed in
sterile saline were analyzed by fluorescence microscopy
using auramine-rhodamine staining. Additionally, solid
(3 % Ogawa medium) and liquid media (BacT/ALERT
MP; bioMérieux, Durham, NC, USA) were used to culture
for mycobacteria from the specimens in sterile saline.
TB-PCR
Nested PCR (for formalin-fixed paraffin-embedded spec-
imens) or real-time PCR (for specimens in sterile saline)
was conducted to detect nucleic acids of M. tuberculosis
using tissue core samples collected by EBUS-TBNA.
For nested PCR, formalin-fixed paraffin-embedded tis-
sues (12-μm thick) were incubated in 1 mL of xylene at
60 °C for 30 min and then centrifuged for 10 min
(8800 rpm). Paraffin and the supernatant were removed
from the samples after centrifugation. The same proce-
dures were repeated until deparaffinization was complete.
After adding 1 mL of alcohol, the samples were centri-
fuged for 5 min (8800 rpm), and the supernatant was re-
moved. The samples were then air-dried as pellets. DNA
was extracted using QIAamp (Qiagen, Valencia, CA, USA)
according to the manufacturer’s instructions. PCR amplifi-
cations were performed using M. tuberculosis IS6110
primers (MTB-PCR kit; Biosewoom, Seoul, South Korea)
according to the manufacturer’s instructions. The first
round using outer primers and the second round using
inner primers amplified a 256- and 181-bp fragment,
respectively. Finally, the PCR products were visualized
in a 2 % agarose gel.
For real-time PCR, specimens in sterile saline were fil-
tered and 1 mL of phosphate-based saline was added.
After centrifugation for 3 min (13,000 rpm), the super-
natant was removed. Next, 50 μL of extraction buffer
was added to the sample, and the sample was heated at
100 °C for 20 min. After centrifugation for 3 min
(13,000 rpm), the supernatant was used in PCR. Real-
time PCR was performed using the AdvanSure TB/NTM
real-time PCR kit (LG Life Science, Seoul, South Korea)
according to the manufacturer’s protocol. Three chan-
nels were used in the real-time PCR reaction (M. tuber-
culosis complex, mycobacteria, and internal control).
Signals for FAM, HEX, and Cy5 were measured in each
channel. M. tuberculosis was considered present if the
cycle threshold of rpoB was less than 35 in each signal
and greater than or equivalent to that of IS6110.
Diagnosis of tuberculous lymphadenitis and sarcoidosis
Tuberculous lymphadenitis was regarded as present
when M. tuberculosis was cultured in EBUS-TBNA sam-
ples. Patients with histological findings suggesting tuber-
culosis (granulomatous reaction with caseation necrosis
Eom et al. BMC Pulmonary Medicine  (2015) 15:166 Page 2 of 7
or multinucleated giant cells associated with epithelioid
histiocytes) or radiological findings compatible with tu-
berculous lymphadenitis (CT findings of nodes with cen-
tral low attenuation and peripheral rim enhancement)
were also considered to have tuberculosis only if clinical
and radiological improvement was achieved after the
standard anti-tuberculosis treatment [13]. Clinical and
radiological improvement was defined as disappearance
of symptoms and a decrease in the size of lymph nodes
at a follow-up radiological examination. The diagnosis of
sarcoidosis required compatible clinical and radiological
results, exclusion of other granulomatous diseases with a
similar histological or clinical picture (e.g., tuberculous
lymphadenitis), and histological demonstration of non-
caseating granulomas [1, 3].
Classification of granulomatous inflammation
Histological specimens were classified into five grades as
previously reported [14]: I) epithelioid granulomatous
reaction with caseation, II) epithelioid granulomatous
reaction without caseation, III) nongranulomatous reac-
tion with necrosis, IV) nonspecific, and V) inadequate
sample. If two or more lymph nodes were examined in
one patient, the most suitable specimen for diagnosis
was selected for analysis.
Statistical analysis
Analyses were conducted on a per-patient basis according
to the final diagnosis and results of the TB-PCR tests. All
categorical and continuous variables are shown as num-
bers (percentages) and means (standard deviation), re-
spectively. The overall diagnostic accuracy of TB-PCR for
tuberculous lymphadenitis was calculated as follows: diag-
nostic accuracy (%) = number of patients with IGL who
were accurately diagnosed (total number of true-positive
and true-negative cases)/total number of patients with
IGL [15]. P values of <0.05 were considered to indicate
significance. All analyses were conducted using SPSS for
Windows version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Study population
Using EBUS-TBNA, 82 lymph nodes were examined in
46 patients with IGL. All of the patients showed negative
results using a screening assay for antibody to human
immunodeficiency virus. Baseline characteristics are
shown in Table 1. The mean age of the patients was
47.1 ± 17.1 years and there were 28 (61 %) female pa-
tients. The mean shortest diameter of lymph nodes that
were examined using EBUS-TBNA was 17.7 ± 5.0 mm
(median, 17.9 mm) in patients with sarcoidosis and
Fig. 1 Study flow diagram. *Of the five patients with reactive hyperplasia, two were confirmed by subsequent mediastinoscopy, and a CT scan of
the remaining three patients showed decreased or unchanged lymph node sizes. †All five patients with anthracotic lymph nodes were followed
up for more than 6 months, and the lymph node size was decreased or unchanged on subsequent CT. ‡In six patients who were lost to follow-up, the
results of EBUS-TBNA were insufficient specimens in three patients and reactive hyperplasia in the other patients. §Histological specimens were classified
into five grades: I) epithelioid granulomatous reaction with caseation, II) epithelioid granulomatous reaction without caseation, III) nongranulomatous
reaction with necrosis, IV) nonspecific, and V) inadequate sample. EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration;
IGL, intrathoracic granulomatous lymphadenopathy; TB-PCR, polymerase chain reaction for Mycobacterium tuberculosis
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22.6 ± 11.3 mm (median, 20.0 mm) in patients with
tuberculous lymphadenitis.
Diagnosis of tuberculous lymphadenitis and sarcoidosis
Of the 46 patients with IGL, 16 with tuberculous lymph-
adenitis and 30 with sarcoidosis were identified. Sputum
acid-fast bacilli smear and M. tuberculosis culture were
positive in 13 % (2/16) and 19 % (3/16) of patients with
tuberculous lymphadenitis, respectively. According to
the results of the M. tuberculosis culture, three patients
had a confirmative diagnosis of tuberculous lymphaden-
itis. Based on the clinical and radiological responses after
anti-tuberculosis treatment or histological results, the
remaining 13 patients were diagnosed with tuberculous
lymphadenitis. Of 30 patients with sarcoidosis, 28 were
diagnosed according to compatible clinical, radiological,
and laboratory results with demonstration of noncaseat-
ing granulomas using EBUS-TBNA samples. Mediasti-
noscopy was subsequently performed in one patient
whose EBUS-TBNA was shown to be anthracotic pig-
mentation with inflammation (Patient 1 in Table 2). The
surgical specimen showed chronic granulomatous in-
flammation without caseous necrosis, and sarcoidosis
was finally diagnosed with compatible radiological and
laboratory results. Another patient whose EBUS-TBNA
samples were shown to be inadequate (grade V) refused
mediastinoscopy. Therefore, she was followed up for
more than 12 months and clinically diagnosed with
sarcoidosis based on radiological and laboratory results
(Patient 6 in Table 2).
Diagnostic performance of TB-PCR
Nested PCR and real-time PCR were performed in 29
and 17 patients, respectively. TB-PCR was not detected
in all patients with sarcoidosis. Of 16 patients with tu-
berculous lymphadenitis, nine showed positive TB-PCR
results. The sensitivity, specificity, positive predictive
value, and negative predictive value were 56 % (95 % CI
[confidence interval], 29.9–81.2), 100 % (95 % CI, 88.3–
100.0), 100 % (95 % CI, 66.2–100.0), and 81 % (95 % CI,
64.8–92.0), respectively. There was no difference in the
diagnostic performance between nested and real-time
TB-PCR. In addition, the overall diagnostic accuracy of
TB-PCR for tuberculous lymphadenitis was 85 % in
patients with IGL.
Classification of histology
Histological results were grades I to III in 39 patients
(85 %) and grades IV to V in seven patients (15 %)
(Table 3). Four (9 %) and three (7 %) patients with
grade IV and V disease, respectively, regarded as non-
diagnostic, also showed non-diagnostic microbiological
results of acid-fast bacilli smear and culture. Two patients
who underwent mediastinoscopy were eventually diag-
nosed with sarcoidosis and tuberculous lymphadenitis
(Patients 1 and 5, respectively, Table 2). Four (57 %) of
seven patients with grades IV to V disease had positive
TB-PCR results. All four patients achieved clinical and
radiological improvement after anti-tuberculosis treat-
ment (Patients 2, 3, 4, and 7 in Table 2).
Diagnostic yield of EBUS-TBNA
The overall diagnostic yield of the combined histological
and microbiological data was 85 %. When the results
of TB-PCR were combined with the histological and
microbiological data, the overall diagnostic yield increased
to 94 %.
Discussion
In addition to acid-fast bacilli smear and culture, TB-
PCR using sputum specimens is traditionally recognized
as a useful examination in the diagnosis of pulmonary
tuberculosis. Similar to pulmonary tuberculosis, TB-PCR
using fine needle aspiration samples of cervical, axillary,
or inguinal lymph nodes has also been reported as a use-
ful molecular test [16, 17]. In the present study, we
found that the sensitivity, specificity, positive predictive
value, negative predictive value, and overall diagnostic
accuracy of TB-PCR using EBUS-TBNA samples in
patients with IGL were 56, 100, 100, 81, and 85 %,
Table 1 Baseline characteristics of 46 patients with intrathoracic
granulomatous lymphadenopathy
Variables No. (%) or mean ± SD
Age 47.1 ± 17.1
Female gender 28 (61)
Number of LN involved per patienta 7.0 ± 3.6
Number of LN examined per patient 1.7 ± 0.7
Number of needle pass per LN 3.7 ± 1.8
Number of tissue core achieved per LN 2.0 ± 1.3
Stations of LN puncturedb
2R 2/82 (2)
4R 31/82 (38)




11 L 3/82 (4)
Diameter of LN examined using EBUS-TBNAc
Shortest diameter, mm 19.4 ± 8.0
Longest diameter, mm 28.7 ± 11.4
aInvolved lymph node was defined as the shortest diameter≥ 1 cm on a CT scan
bBased on the International Association for the Study of Lung Cancer (IASLC)
lymph node map
cMeasured on an axial CT scan
SD, standard deviation; LN, lymph node; EBUS-TBNA, endobronchial
ultrasound-guided transbronchial needle aspiration
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respectively. Additionally, when we compared the
diagnostic yield of combined histological and micro-
biological examinations using EBUS-TBNA samples with
a combination of the three modalities of TB-PCR, histology,
and microbiology, the diagnostic yield increased from 85 to
94 % in patients with IGL. The results of the current study
are in line with those of previous reports regarding
TB-PCR with lymph nodes other than mediastinal IGLs.
The most important role of EBUS-TBNA in patients
with mediastinal lymphadenopathy is to prevent medias-
tinoscopy with general anesthesia. A previous study of
isolated mediastinal lymphadenopathy reported that
EBUS-TBNA prevented 87 % of mediastinoscopies [7].
In the present study, seven patients had non-diagnostic
EBUS-TBNA results (grade IV or V). Of them, TB-PCR
was detected in four patients. In these four patients,
anti-tuberculosis treatment led to clinical and radio-
logical improvement. Therefore, the TB-PCR test could
be effective and prevent mediastinoscopy when EBUS-
TBNA results are non-diagnostic. Our findings suggest
that TB-PCR using EBUS-TBNA samples could extend
the role of EBUS-TBNA to prevent mediastinoscopy.
In a previous study of tuberculous lymphadenitis by
Navani et al. [8], the diagnostic yield of combined histo-
logical and microbiological tests using EBUS-TBNA
samples was much higher than that in the present study;
the sensitivity was 94 %, and M tuberculosis was cultured
in 47 % of samples. Histological and microbiological
tests using EBUS-TBNA samples appear to be sufficient
for the diagnosis of tuberculous lymphadenitis. However,
the lymph node size examined by EBUS-TBNA in previ-
ous studies was larger than that in the current study
(median, 22.0 vs. 20.0 mm, respectively). The bioburden
of M. tuberculosis in tuberculous lymphadenitis might
have been much higher in the previous study by Navani
et al. compared with the current study [8].
Previous studies applied TB-PCR using EBUS-TBNA
samples as follows. Geake et al. reported that the sensitiv-
ity and specificity of TB-PCR using EBUS-TBNA samples
were 38 and 100 %, respectively [18]. However, TB-PCR
was performed in 29 of 39 patients with tuberculous
Table 2 Detailed characteristics of seven patients with grade IV or V for histological results
Characteristics Patient number
1 2 3 4 5 6 7
Sex Female Male Male Female Female Female Female
Age, years 65 78 27 73 63 33 56
Number of LN involved per patienta 3 3 3 2 4 8 4
Number of LN examined per patient 1 2 1 2 2 2 1
Number of needle pass per LN 6 4 and 2 4 3 and 3 2 and 2 6 and 2 1
Number of tissue core
achieved per LN
2 0 and 2 1 1 and 2 2 and 2 1 and 1 0
Stations of LN punctured 7 7 and 11R 4R 4R and 10R 2R and 4R 4R and 7 4R
Shortest diameter of LN
punctured, mm
10.6 13.0 and 15.0 32.4 18.9 and 12.2 14.6 and 10.5 17.2 and 12.6 15.7
Results of EBUS-TBNA samples
Acid-fast bacilli smear Negative Negative Negative Negative Negative Negative Negative
Acid-fast bacilli culture Negative Negative Negative Negative Negative Negative Negative
TB-PCR Not detected MTB detected MTB detected MTB detected Not detected Not detected MTB detected
Histological grade IV IV IV IV V V V
Mediastinoscopy Performed Not performed Not performed Not performed Performed Not performed Not performed
Final diagnosis Sarcoidosis TBL TBL TBL TBL Sarcoidosisb TBL
aLymph nodes with the shortest diameter ≥ 10 mm on an axial CT scan
bPatient 6 was clinically diagnosed with sarcoidosis based on radiological and laboratory results after more than 12 months of follow-up
LN, lymph node; EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration; TB-PCR; polymerase chain reaction for Mycobacterium tuberculosis;
MTB, Mycobacterium tuberculosis; TBL, tuberculous lymphadenitis
Table 3 Results of histological examinations
Grade Results of polymerase chain reaction for Mycobacterium tuberculosis
Sarcoidosis Tuberculous lymphadenitis
I 0/0 (0) 5/8 (63)
II 0/28 (0) 0/1 (0)
III 0/0 (0) 0/2 (0)
IV 0/1 (0) 3/3 (100)
V 0/1 (0) 1/2 (50)
Total 0/30 (0) 9/16 (56)
Data are presented as the number of positive results/number of patients who
received a test (%)
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lymphadenitis, and thus selection bias might have influ-
enced their results. Senturk et al. analyzed 30 patients
who were diagnosed with tuberculous lymphadenitis (27
patients with EBUS-TBNA samples and three with med-
iastinoscopic samples) [19]. Analysis of TB-PCR was per-
formed with a sensitivity of 57 % and specificity of 100 %.
Generally, tissue specimens collected by mediastinoscopy
are larger than those collected by EBUS-TBNA. Therefore,
the sensitivity and specificity of TB-PCR presented by
Senturk et al. could not be used to interpret the results of
TB-PCR using EBUS-TBNA samples. Dhasmana et al.
analyzed the performance of Xpert MTB/RIF in the diag-
nosis of mediastinal tuberculous lymphadenitis [20]. They
showed that Xpert MTB/RIF had a higher sensitivity
(73 %) than that found in our study (56 %). Dhasmana
et al. performed Xpert MTB/RIF in patients with culture-
positive tuberculous lymphadenitis. However, our study
population consisted of culture-negative cases with clin-
ical suspicion, as well as culture-positive tuberculous
lymphadenitis. Not all mediastinal tuberculous lymph-
adenitis samples would have shown a positive culture for
M. tuberculosis. Therefore, Dhasmana et al.’s results might
have overestimated the diagnostic performance of Xpert
MTB/RIF.
There are several limitations in this study. First, the
present study was performed retrospectively. Although
the data were collected prospectively, TB-PCR was not
performed in four of the 50 selected patients with IGL
(Fig. 1). We acknowledge that there was potential for se-
lection bias, which might have influenced our results.
Second, our study included a relatively small sample size.
Third, we could not unify the PCR methods. To date,
which method of TB-PCR is superior for detection of
M. tuberculosis remains unknown. These limitations
need to be verified in prospective trials with larger
study populations and a uniform study protocol.
Conclusions
TB-PCR using EBUS-TBNA samples is a useful laboratory
test for diagnosing IGL. Moreover, this method can prevent
further invasive evaluation in patients whose histological
and microbiological tests are non-diagnostic.
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